Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Calcium Channel
    (7)
  • Potassium Channel
    (7)
  • Sodium Channel
    (7)
  • P-gp
    (3)
  • Autophagy
    (2)
  • Drug Metabolite
    (2)
  • iGluR
    (2)
  • Adenosine Receptor
    (1)
  • Adrenergic Receptor
    (1)
  • Others
    (10)
Filter
Search Result
Results for "

channel block

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    25
    TargetMol | All_Pathways
  • Compound Libraries
    3
    TargetMol | Compound_Libraries
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Isotope Products
    2
    TargetMol | Isotope_Products
  • Antibody Products
    3
    TargetMol | Antibody_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
N-type calcium channel blocker-1
T12153241499-17-2
N-type calcium channel blocker-1 is an orally active analgesic agent with a high affinity for functionally blocking N-type calcium channels.
  • $1,820
8-10 weeks
Size
QTY
M2 ion channel blocker
T119271190215-03-2
M2 ion channel blocker ,Antiviral agent, is capable of inhibiting and blocking the activity of M2 ion channel.
  • $1,520
6-8 weeks
Size
QTY
NaV1.2/1.6 channel blocker-1
T721701199944-04-1
NaV1.2/1.6 channel blocker-1 is a potent inhibitor of NaV1.2 and NaV1.6 channels, exhibiting inhibitory effects on rNaV1.6 and hNaV1.2. This compound can be utilized in the study of generalized epilepsy and movement disorders.
  • $34
In Stock
Size
QTY
IEM 1754 2HBr
IEM 1754 dihydrobromide
T6134162831-31-4In house
IEM 1754 2HBr (IEM 1754 dihydrobromide) is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC50 of 6 μM.
  • $30
In Stock
Size
QTY
Propafenone
Rythmol, Propafenonum
T086654063-53-5
Propafenone (Propafenonum) is only found in individuals that have used or taken this drug. It is an antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated. The electrophysiological effect of propafenone manifests itself in a reduction of upstroke velocity (Phase 0) of the monophasic action potential. In Purkinje fibers, and to a lesser extent myocardial fibers, propafenone reduces the fast inward current carried by sodium ions, which is responsible for the drugs antiarrhythmic actions. Diastolic excitability threshold is increased and effective refractory period prolonged. Propafenone reduces spontaneous automaticity and depresses triggered activity. At very high concentrations in vitro, propafenone can inhibit the slow inward current carried by calcium but this calcium antagonist effect probably does not contribute to antiarrhythmic efficacy.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Norverapamil
D591, (±)-Norverapamil
T1224467018-85-3
Norverapamil is a blocker of L-type calcium channel and an inhibitor of P-glycoprotein (P-gp) function .
  • $1,520
1-2 weeks
Size
QTY
Raxatrigine hydrochloride
GSK-1014802 hydrochloride, CNV1014802 (hydrochloride)
T14992934240-31-0
Raxatrigine hydrochloride is a state-dependent sodium channel blocker and a Nav1.7 sodium channel inhibitor.
  • $88
5 days
Size
QTY
Lanicemine
AZD6765
T15706153322-05-5
Lanicemine is a low-trapping NMDA channel blocker. It also has a binding (Ki: 0.56-2.1 μM).
  • $238
35 days
Size
QTY
Norverapamil hydrochloride
D591 hydrochloride, (±)-Norverapamil hydrochloride
T1633967812-42-4
Norverapamil hydrochloride (D591 hydrochloride) ((±)-Norverapamil hydrochloride) is an N-demethylated metabolite of Verapamil and it is an L-type calcium channel blocker and a P-glycoprotein (P-gp) function inhibitor.
  • $31
In Stock
Size
QTY
Calcium channel-modulator-1
T10101136941-70-3In house
Calcium channel-modulator-1, a calcium channel-modulator (IC50: 0.8 μM), specializes in blocking aortic constriction.
  • $115
In Stock
Size
QTY
(-)-Epicatechin gallate
Epicatechin gallate, ECG, (−)-Epicatechin 3-gallate, (-)-Epicatechin 3-O-gallate, (-)-Epicatechin 3-gallate
T27321257-08-5
(-)-Epicatechin gallate ((-)-Epicatechin 3-O-gallate) is one of the catechin isomers and a potent antioxidant that can modulate a wide range of membrane proteins. Its bilayer-modifying potency was tested using gramicidin A (gA) channels as probes. All the catechins alter gA channel function and modify bilayer properties, with a 500-fold range in potency. The gallate group causes current block, as evident by brief downward current transitions.
  • $50
In Stock
Size
QTY
TargetMol | Citations Cited
Paxilline
T1237357186-25-1
Paxilline is an indole alkaloid mycotoxin from *Penicillium paxilli*, acting as a potent BK channel inhibitor via an almost exclusively closed-channel block mechanism. Paxilline possesses significant anticonvulsant activity.
  • $399
7-10 days
Size
QTY
VU591 hydrochloride
T133201315380-70-1
VU591 hydrochloride is a selective renal outer medullary potassium channel (Kir1.1, ROMK) antagonist (IC50:0.24 μM). Thought to block the intracellular pore of the Kir1.1 channel. Exhibits no effect on Kir7.1 at concentrations up to 10 μM; does not inhibi
  • $30
In Stock
Size
QTY
MRS 1523
T16135212329-37-8
MRS 1523 can exert an antihyperalgesic effect through N-type Ca channel block and action potential inhibition in isolated rat dorsal root ganglion (DRG) neurons. MRS 1523 is an effective and selective adenosine A3 receptor antagonist Ki: 18.9 nM and 113 n
  • $198
35 days
Size
QTY
Triamterene D5
T195911189922-23-3
Triamterene D5 is a deuterium-labeled Triamterene and can block epithelial Na+ channel (ENaC) in a voltage-dependent manner, used as a mild diuretic.
  • $228
7-10 days
Size
QTY
NeoSTX
neosaxitoxina, Neosaxitoxin solution, Neosaxitoxin
T20288464296-20-4
NeoSTX (Neosaxitoxin) is a specific sodium channel blocker that targets site 1. It works synergistically with local anesthetics to provide surgical anesthesia through peripheral nerve block or local infiltration and significantly prolongs postoperative analgesia duration.
  • Inquiry Price
10-14 weeks
Size
QTY
Spadin Acetate
Spadin Acetate(1270083-24-3 Free base)
T22178L
Spadin Acetate is a natural peptide derived from a propeptide released in blood. Spadin Acetate is able to block the TREK-1 channel activity. Spadin Acetate binds specifically to TREK-1 with an affinity of 10 nM.
  • $98
In Stock
Size
QTY
Detajmium
Tachmalcor
T2531247719-70-0
Detajmium is an anti-arrhythmia compound. It is an Na(+)-channel-blocking drug with an extremely long recovery from use-dependent sodium channel block.
  • Inquiry Price
3-6 months
Size
QTY
NS-638
NS 638
T3543150493-34-8
NS-638 is a Ca2+-channel blocker. It can block K+-stimulated intracellular Ca2+-elevation (IC50: 3.4 μM).
  • $39
In Stock
Size
QTY
Ropivacaine mesylate
T61475854056-07-8
Ropivacaine mesylate, a long-acting amide local anaesthetic, is used for spinal block and effectively mitigates neuropathic pain. It achieves analgesia by reversibly inhibiting sodium ion influx in nerve fibers, thus blocking impulse conduction. Additionally, Ropivacaine acts as an inhibitor of the K2P (two-pore domain potassium channel) TREK-1, exhibiting an IC50 of 402.7 μM in COS-7 cell membranes.
    Inquiry
    TRAM-34
    Triarylmethane-34, TRAM 34
    T6186289905-88-0
    TRAM-34 (Triarylmethane-34) (Kd=20 nM), an effective and specific inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1), does not block cytochrome P450. The selective activity of TRAM-34(TRAM 34) is 200 to 1500-fold than other ion channels.
    • $43
    In Stock
    Size
    QTY
    Relutrigine
    PRAX-562, PRAX562, PRAX 562
    T696522392951-29-8
    Relutrigine (PRAX-562) is an orally active, long-acting sodium current inhibitor that preferentially suppresses sustained INa induced by TX-II or SCN8A N1768D mutations (IC50=141/75 nM). It reduces neuronal intrinsic excitability and may be used for anticonvulsant therapy.
    • $289
    In Stock
    Size
    QTY
    Glyburide-d11
    TMID-10781189985-02-1
    Glyburide-d11 is a deuterated form of Glibenclamide. Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor used in the study of diabetes and obesity. It inhibits P-glycoprotein and directly binds to block the SUR1 subunit of KATP, also inhibiting cystic fibrosis transmembrane conductance regulator (CFTR). Glibenclamide interferes with mitochondrial bioenergetics by inducing membrane ion permeability and can induce autophagy.
    • Inquiry Price
    Inquiry
    Size
    QTY
    (-)-Epicatechin gallate (Standard)
    ECG (Standard), (-)-epicatechin-3-O-gallate (Standard)
    TMSM-08621257-08-5
    (-)-Epicatechin gallate (Standard) is a reference standard for research and analysis in studies involving (-)-Epicatechin gallate. (-)-Epicatechin gallate ((-)-Epicatechin 3-O-gallate) is one of the catechin isomers and a potent antioxidant that can modulate a wide range of membrane proteins. Its bilayer-modifying potency was tested using gramicidin A (gA) channels as probes. All the catechins alter gA channel function and modify bilayer properties, with a 500-fold range in potency. The gallate group causes current block, as evident by brief downward current transitions.
    • $176
    7-10 days
    Size
    QTY